Four decades on and Heeney is at the helm of DIOSynVax, a biotechnology company based in Cambridge, UK, who recently received a $42m (£34m/€41m) grant from the Coalition for Epidemic Preparedness Innovations (CEPI), the foundation backed by Bill and Melinda Gates, the Indian and Norwegian governments, and the World Economic Forum, among others.